CD8+ and CD4+ effector cells and regulatory T cells from urine precisely signaled the immune response of the body and provided a map of the tumor microenvironment (TME), which offers researchers the potential to determine the tumor’s stage and status [160]. The gene discussed is CD8A; the disease is neoplasm.